About 77,385 results

ALLMedicine™ Squamous Cell Carcinoma Center

Research & Reviews  26,840 results

Malignant Melanoma Arising from Esophageal Melanosis and Synchronous with Esophageal Sq...
The American Journal of Case Reports; Ota Y, Iwasaki K et. al.

Feb 5th, 2023 - BACKGROUND Primary malignant melanoma of the esophagus is a rare disease. However, its exact etiology and progression from melanosis to malignant melanoma have not been elucidated due to its rarity. CASE REPORT We report a case of esophageal melan...

A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous...
The British Journal of Dermatology; Borghi A, D'Abundo L et. al.

Feb 5th, 2023 - A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma.|2023|Borghi A,D'Abundo L,Bassi C,Lupini L,Tagliatti V,|

MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma ...
Journal of Experimental & Clinical Cancer Research : CR; Hsiao SY, Weng SM et. al.

Feb 5th, 2023 - Lymph node and distant metastasis contribute to poor outcomes in patients with oral squamous cell carcinoma (OSCC). The mechanisms regulating cancer migration and invasion play a key role in OSCC. We determined migration and invasion ability of OS...

Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous c...
Journal of Cranio-maxillo-facial Surgery : Official Publi... Bonavolontà P, Improta G et. al.

Feb 5th, 2023 - This retrospective single-center study aimed to evaluate the relevance of sarcopenia and sarcopenic obesity as negative prognostic factors in patients with oral squamous cell carcinoma (OSCC). The study was performed on patients who underwent oral...

Use of methotrexate and risk of skin cancer: a nationwide case-control study.
British Journal of Cancer; Polesie S, Gillstedt M et. al.

Feb 5th, 2023 - Methotrexate (MTX) use has been suspected of increasing the risk of skin cancer. The aim of this investigation was to examine the association between the use of MTX and the risk of basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSC...

see more →

Guidelines  37 results

ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT...
Practical Radiation Oncology; Damico N, Meyer J et. al.

Jun 19th, 2022 - Previous anal cancer guidelines delineate target volumes similarly for all patients with squamous cell carcinoma of the anal canal and/or perianal skin (SCCA), regardless of disease stage. The purpose of this guideline is to provide customized rad...

Clinical features, molecular characteristics and surgical management of primary penile ...
Melanoma Research; Cakir OO, Pozzi E et. al.

Nov 30th, 2021 - Penile mucosal melanoma is an aggressive and rare genital malignancy. The aim of the present study was to review the management and outcomes of a homogenous cohort of patients with histologically confirmed penile mucosal melanoma, at a single spec...

Poor tumor differentiation is an independent adverse prognostic variable in patients wi...
Cancer Medicine; Lee LY, Lin CY et. al.

Sep 18th, 2021 - We sought to compare the prognostic impact of tumor differentiation with respect to adverse risk factors (RFs) identified by the National Comprehensive Cancer Network (NCCN) guidelines--including extranodal extension (ENE), positive/close margins,...

ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer.
Journal of the American College of Radiology : JACR; , Lakhman Y et. al.

May 8th, 2021 - Vulvar cancer is an uncommon gynecologic tumor and one of several human papillomavirus-associated malignancies. Squamous cell carcinoma is the most prevalent histologic subtype of vulvar cancer, accounting for the majority of cases. Imaging plays ...

Summary of the updated 2020 guidelines for cutaneous squamous cell carcinoma.
Clinical and Experimental Dermatology; Woo WA, Suarez M-Falero B et. al.

Mar 18th, 2021 - Summary of the updated 2020 guidelines for cutaneous squamous cell carcinoma.|2021|Woo WA,Suarez M-Falero B,Keohane SG,|pathology,therapy,pathology,therapy,

see more →

Drugs  71 results see all →

Clinicaltrials.gov  1,915 results

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Added to Radiation or Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent H...

Feb 3rd, 2023 - PRIMARY OBJECTIVES: I. To evaluate overall survival (OS) of adjuvant reirradiation plus concurrent pembrolizumab followed by pembrolizumab to complete 12 months total of pembrolizumab to adjuvant reirradiation plus concurrent platinum chemotherapy...

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Feb 3rd, 2023 - Study Description: Individuals undergoing cisplatin-based chemoradiation therapy are at risk for developing significant, permanent hearing loss. The cholesterol-lowering drug atorvastatin has the potential to reduce the incidence and severity of h...

Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype

Feb 3rd, 2023 - BACKGROUND: Glioma is the most common malignant brain tumor. Genes coding for isocitrate dehydrogenases 1and 2 (IDH1 and IDH2), metabolic enzymes, are frequently mutated in gliomas, particularly lower-grade gliomas (LGGs). IDH1/2 mutation causes a...

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Car...

Feb 3rd, 2023 - This study is designed to assess the safety and efficacy of lenvatinib in combination with pembrolizumab versus standard of care (SOC) chemotherapy, and to also assess the safety and efficacy of lenvatinib monotherapy in participants with recurren...

A Single Dose of Pembrolizumab in HIV-Infected People

Feb 3rd, 2023 - A subset of HIV-infected patients, those with poor immunologic response to combined antiretroviral therapy (CD4+ T-cell count of less than 300-350 cells/mm^3) despite control of viremia, are at increased risk for both HIV-related and non-HIV-relat...

see more →

News  2,030 results

Adding Docetaxel to RT Improves Survival in Cisplatin-Ineligible Head & Neck Cancer

Feb 3rd, 2023 - Adding docetaxel to radiation therapy (RT) improved survival outcomes in cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase III randomized trial showed. At a median follow-up of 32.4 months, the 2-ye...

Chronic Ulcerative Lesion
Sonia Himed, BS, Catherine Chung, MD et. al.

Jan 25th, 2023 - The Diagnosis: Marjolin Ulcer A skin biopsy during his prior hospital admission demonstrated an ulcer with granulation tissue and mixed inflammation, and the patient was discharged with close outpatient follow-up. Two repeat skin biopsies from the.

Methacrylate Polymer Powder Dressing for a Lower Leg Surgical Defect
Matthew J. Lin, MD, Danielle P. Dubin, MD et. al.

Jan 13th, 2023 - To the Editor: Surgical wounds on the lower leg are challenging to manage because venous stasis, bacterial colonization, and high tension may contribute to protracted healing. Advances in technology led to the development of novel, polymer-based w.

Scar overgrowth
MDedge Family Medicine;

Jan 4th, 2023 - Dermatopathology was consistent with a diagnosis of cutaneous myxoma (CM). There are very few dermoscopic descriptions of CM in the literature, so diagnostic features are not established.

Rapidly Growing Nodule Within a Previously Radiated Area of the Scalp
Anthony Thompson, BS, Alexzandra Mattia, BS et. al.

Jan 3rd, 2023 - The Diagnosis: Pseudoangiomatous Squamous Cell Carcinoma Pseudoangiomatous squamous cell carcinoma (PSCC), a variant of acantholytic squamous cell carcinoma (SCC), is a rare epithelial neoplasm that can mimic angiosarcoma. 1 Clinically, PSCC presen.

see more →

Patient Education  61 results see all →